Skip to main content
. Author manuscript; available in PMC: 2014 Feb 13.
Published in final edited form as: Clin Cancer Res. 2011 Dec 12;18(3):666–677. doi: 10.1158/1078-0432.CCR-11-1867

Figure 2.

Figure 2

Results of aCGH analyses. A, Principal component analysis (PCA). B, Copy number variations (CNVs) in SCPC/LCNEC (blue) and adenocarcinoma (red) xenografts. C, aCGH of the UBE2C, CCND1, AR, and RB1 genetic loci (SCPC/LCNEC xenografts are shown in blue and adenocarcinoma xenografts in red)

HHS Vulnerability Disclosure